Resources
Practice resources
Product Information, patient education materials, and other resources.
Patient Information
Patient information on Multiple Myeloma, Products, and patient resources like financial support and and copay cards.
Myeloma News
Powered By:
- Oncopeptides Enrolls the First Patient in the Phase 3 LIGHTHOUSE Combination Study in Multiple Myeloma
- FDA Approves Karyopharm’s Xpovio To Treat Multiple Myeloma After At Least One Prior Therapy
- Janssen Initiates Rolling Submission of a Biologics License Application to U.S. FDA for BCMA CAR-T Therapy Ciltacabtagene Autoleucel (cilta-cel) for the Treatment of Relapsed and/or Refractory Multiple Myeloma
- FDA Approves Selinexor For Refractory Or Relapsed Multiple Myeloma
- ONJ Incidence Determined by S0702
- Cerecor Announces First Patient Dosed in a Phase 1b Clinical Trial of CERC-007 for the Treatment of Relapsed or Refractory Multiple Myeloma
- Karyopharm Announces National Comprehensive Cancer Network® Adds Three XPOVIO® (selinexor) Treatment Regimens to Its Clinical Practice Guidelines in Oncology for Multiple Myeloma
- ASH 2020: GPRC5D Is a New Target of Interest for Multiple Myeloma
- Year in Review: Hematologic Malignancies
- Sequencing Study from Roswell Park Highlights Previously Unknown Myeloma Resistance Mechanisms